Journal Mobile Options
Table of Contents
Vol. 8, No. 4, 2001
Issue release date: July–August 2001
J Biomed Sci 2001;8:299–306
(DOI:10.1159/000054047)

Modulation of Sympathetic Actions on the Heart by Opioid Receptor Stimulation

Wong T.M. · Shan J.
Department of Physiology, Faculty of Medicine, The University of Hong Kong, Hong Kong

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

The sympathetic nervous system, the most important extrinsic regulatory mechanism of the heart, is inhibited postsynaptically and presynaptically by opioid peptides produced in the heart via their respective receptors. The cardiac actions of β-adrenergic receptor (β-AR) stimulation are attenuated by activation of the opioid receptor (OR) with OR agonist at ineffective concentrations, implying cross-talk between the OR and β-AR. This cross-talk results from inhibition of the Gs protein and adenylyl cyclase of the β-AR pathway by the pertussis toxin-sensitive G protein of the opioid pathway. Alterations in cross-talk between these two receptors occur in pathological situations to meet bodily needs. In myocardial ischemia, when the sympathetic activity is increased, the inhibition of β-AR stimulation by ĸ-opioid stimulation is also enhanced, thus reducing the workload, oxygen consumption and cardiac injury. Whereas cardiac responsiveness to sympathetic discharges is also reduced after chronic hypoxia, the cross-talk between ĸ-OR and β-AR is reduced to prevent undue suppression of the sympathetic influence on the heart. On the other hand, impairment of the cross-talk may result in abnormality. A lack or a significant reduction in the inhibition of β-AR stimulation by ĸ-OR stimulation may lead to an excessive increase in cardiac activities, which contribute to the maintenance of high arterial blood pressure in spontaneously hypertensive rats. Other than opioid peptides, female sex hormone and adenosine also inhibit the sympathetic actions on the heart. In addition, sympathetic action is also inhibited presynaptically by ĸ-opioid peptides via their receptor.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Achterberg PW, de Tombe PP, Harmsen E, De Jong JW. Myocardial S-adenosylhomocysteine hydrolase is important for adenosine production during normoxia. Biochim Biophys Acta 840:393–400;1985.
  2. Baron BA, Gu H, Gangl JL. Screening for opioids in dog heart. J Mol Cell Cardiol 24:67–77;1992.
  3. Bian J-S, Zhang W-M, Xia Q, Wong TM. Phospholipase C inhibitors attenuate arrhythmias induced by κ-receptor stimulation in the isolated rat heart. J Mol Cell Cardiol 30:2103–2110;1998.
  4. Blake AD, Bot G, Li S, Freeman JC, Resine T. Differential agonist regulation of the human κ-opioid receptor. J Neurochem 68:1846–1852;1997.
  5. Canossa M, Ventura C, Vaona I, Carboni L, Guarnieri C, Spampinato S. Prodynorphin mRNA expression in adult cultured rat ventricular cardiac myocytes. Biochim Biophys Acta 1172:247–250;1993.
  6. Cunningham WL, Becker EJ, Kreuzer F. Catecholamines in plasma and urine at high altitude. J Appl Physiol 20:607–610;1965.
  7. Ela C, Barg J, Vogel Z, Hasin Y, Eilam Y. Distinct components of morphine effects on cardiac myocytes are mediated by the kappa and delta opioid receptors. J Mol Cell Cardiol 29:711–720;1997.
  8. Fenton RA, Moore EDW, Fay FS, Dobson JG Jr. Adenosine reduces the Ca2+ transients of iosproterenol-stimulated rat ventricular myocytes. Am J Physiol 261:C1107–C1114;1991.
  9. Forman LJ, Estilow S, Hock CE. Localization of beta-endorphin in the rat heart and modulation by testosterone. Proc Soc Exp Biol Med 190:240–245;1989.
  10. Fuder H, Buder M, Riers H-D, Rothacher G. On the opioid receptor subtype inhibiting the evoked release of 3H-noradrenaline from guinea-pig atria in vitro. Naunyn Schmiedebergs Arch Pharmacol 332:148–155;1986.
  11. Howe PRC, Provis JC, West MJ, Chalmers JP. Changes in cardiac norepinephrine in spontaneously hypertensive and stroke prone rats. J Cardiovasc Pharmacol 1:115–122;1979.
  12. Huang X-D, Wong TM. Morphine and (D-Ala2, NME-Phe4, Gly-ol)-enkephalin increase the intracellular free calcium in isolated rat myocytes – effect of naloxone or pretreatment with morphine. Life Sci 48:1101–1107;1991.
  13. Judy WV, Watanabe AM, Henry DP, Besch HR Jr, Murphy WR, Hockel GM. Sympathetic nerve activity: Role in regulation of blood pressure in the spontaneously hypertensive rat. Circ Res 38(6 suppl 2):21–29;1976.
  14. Kacimi R, Richalet J-P, Corsin A, Abousahl I, Crozatier B. Hypoxia-induced downregulation of β-adrenergic receptors in rat heart. J Appl Physiol 73:1377–1382;1992.
  15. Kahn RA, Gilman AG. The protein cofactor necessary for ADP-ribosylation of Gs by cholera toxin is itself a GTP binding protein. J Biol Chem 261:7906–7911;1986.
  16. Krumins SA. Characterization of dermorphin binding to membranes of rat brain and heart. Neuropeptides 9:93–102;1987.
  17. Krumins SA, Faden AI, Feuerstein G. Opiate binding in rat hearts: Modulation of binding after hemorrhagic shock. Biochem Biophys Res Commun 127:120–128;1985.
  18. Lahti RA, VonVoigtlander PF, Barsuhn C. Properties of a selective kappa agonist, U-50,488H. Life Sci 31:2257–2260;1982.
  19. Lang RE, Hermann K, Dietz R, Gaida W, Ganten D, Kraft K, Unger T. Evidence for the presence of enkephalins in the heart. Life Sci 32:399–406;1983.
  20. Ledda F, Mantelli L, Corti V, Fantozzi R. Possible presynaptic inhibitory effect of etorphine on sympathetic nerve terminals of guinea-pig heart. Eur J Pharmacol 102:443–450;1982.
  21. Lee AYS, Zhan CY, Wong TM. Effects of β-endorphin on the contraction and electrical activity of the isolated perfused rat heart. Int J Pept Protein Res 24:525–528;1984.
  22. Li H-Y, Bian J-S, Kwan YW, Wong TM. Enhanced responses to 17β-estradiol in rat hearts treated with isoproterenol: Involvement of a cyclic AMP-dependent pathway. J Pharmacol Exp Ther 293:592–598;2000.
  23. Limas C, Limas CJ. Reduced number of β-adrenergic receptors in the myocardium of spontaneously hypertensive rats. Biochem Biophys Res Commun 83:710–714;1978.
  24. Maher JT, Denniston JC, Wolfe DL, Cymerman A. Mechanism of the attenuated cardiac response to β-adrenergic stimulation in chronic hypoxia. J Appl Physiol 44:647–651;1978.
  25. Mantelli L, Corti V, Ledda F. On the presence of opioid receptors in guinea-pig ventricular tissue. Gen Pharmacol 18:309–313;1987.
  26. Meyer R, Linz KW, Surges R, Meinardus S, Vees J, Hoffmann A, Windholz O, Grohe C. Rapid modulation of L-type calcium current by acutely applied oestrogens in isolated cardiac myocytes from human, guinea-pig and rat. Exp Physiol 83:305–321;1998.
  27. Millington WR, Rosenthal DW, Unal CB, Nyquist-Battie C. Localization of pro-opiomelanocortin mRNA transcripts and peptide immunoreactivity in rat heart. Cardiovasc Res 43:107–116;1999.
  28. Mukherjee A, Graham RM, Sagalowsky AI, Pettinger W, McCoy KE. Myocardial beta-adrenergic receptors in the stroke-prone spontaneously hypertensive rat. J Mol Cell Cardiol 12:1263–1272;1980.
  29. Pepe S, Xiao RP, Hohl C, Altschuld R, Lakatta EG. ‘Cross talk’ between opioid peptide and adrenoceptor signaling in isolated rat heart. Circulation 95:2122–2129;1997.
  30. Protoghese PS, Lin CE, Farouz-Grant GF, Takemori AE. Structure-activity relationship of N17′-substituted norbinaltorphimine congeners. Role of the N17′ basic group in the interaction with a putative address subsite on the κ-opioid receptor. J Med Chem 37:1495–1500;1994.
  31. Schomig A, Richardt G. Cardiac sympathetic activity in myocardial ischemia: Release and effects of noradrenaline. Basic Res Cardiol 85:9–30;1990.
  32. Schultz JJ, Hus AK, Gross GJ. Ischemic preconditioning and morphine-induced cardioprotection involve the δ-opioid receptor in the intact rat heart. J Mol Cell Cardiol 29:2187–2195;1997.
  33. Schutz W, Schrader J, Gerlach E. Different sites of adenosine formation in the heart. Am J Physiol 240:H963–H970;1981.
  34. Sheng J-Z, Wong NS, Wang H-X, Wong TM. Pertussis toxin, but not tyrosine kinase inhibitors, abolishes effects of U-50488H on [Ca2+]i in myocytes. Am J Physiol 272:C560–C564;1997.
  35. Spampinato S, Goldstein A. Immunoreactive dynorphin in rat tissues and plasma. Neuropeptides 3:193–212;1983.
  36. Springhorn JP, Claycomb WC. Preproenkephalin mRNA expression in developing rat heart and in cultured ventricular cardiac muscle cells. Biochem J 258:73–77;1989.
  37. Springhorn JP, Claycomb WC. Translation of heart preproenkephalin mRNA and secretion of enkephalin peptides form cultured cardiac myocytes. Am J Physiol 263:H1560–H1566;1992.
  38. Starke K, Schoffel E, Illes P. The sympathetic axons innervating the sinus node of the rabbit possess presynaptic opioid κ- but not μ- or δ-receptors. Naunyn Schmiedebergs Arch Pharmacol 329:206–209;1985.
  39. Steel PA, Aromataris EC, Riederer BM. Endogenous opioid peptides in parasympathetic, sympathetic and sensory nerves in the guinea-pig heart. Cell Tissue Res 284:331–339;1996.
  40. Tai KK, Bian CF, Wong TM. κ-opioid receptor stimulation increases intracellular free calcium in isolated rat ventricular myocytes. Life Sci 51:909–913;1992.
  41. Tai KK, Jin WQ, Chan TKY. Characterization of [3H]U69593 binding sites in the rat heart by receptor binding assays. J Mol Cell Cardiol 23:1297–1302;1991.
  42. Tang LX, Wang HX, Cho CH, Wong TM. Reduced responsiveness of [Ca2+]i to adenosine A1- and A2-receptor stimulation in the isoproterenol-stimulated ventricular myocytes of spontaneously hypertensive rats. J Cardiovasc Pharmacol 31:493–498;1998.
  43. Ventura C, Bastagli L, Bernardi P, Caldarera CM, Guarnieri C. Opioid receptors in rat cardiac sarcolemma: Effect of phenylephrine and sioproterenol. Biochim Biophys Acta 987:69–74;1989.
  44. Ventura C, Pintus G. Opioid peptide gene expression in the primary hereditary cardiomyopathy of the Syrian hamster. J Biol Chem 272:6699–6705;1997.
  45. Ventura C, Spurgeon H, Lakatta EG, Guarnieri C, Capogrossi MC. κ- and δ-opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons. Circ Res 70:66–81;1992.
  46. Viveros OH, Wilson SP. The adrenal chromaffin cell as a model to study the co-secretion of enkephalins and catecholamines. J Auton Nerv Syst 7:41–58;1983.
  47. Voekel NF, Hegstrand L, Reeves JT, McMurty IF, Molinoff PB. Effects of hypoxia on density of β-adrenergic receptors. J Appl Physiol 50:363–366;1981.
  48. Vonvoigtlander PF, Lahti RA, Ludens JH. U-50,488: A selective and structurally novel non-μ (κ) opioid agonist. J Pharmacol Exp Ther 224:7–12;1983.
  49. Wang GY, Wu S, Pei JM, Yu XC, Wong TM. κ- but not δ-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats. Am J Physiol 280:H384–H391;2001.
  50. Wegener K, Kummer W. Sympathetic noradrenergic nerve fibers as the source of immunoreactive alpha-neoendorphin and dynorphin in the guinea pig heart. Acta Anat (Basel) 151:112–119;1994.
  51. Weihe E, McKnight AT, Corbett AD, Hartschuh W, Reinecke M, Kosterlitz HW. Characterization of opioid peptides in guinea-pig heart and skin. Life Sci 33:711–714;1983.
  52. Weihe E, McKnight AT, Corbett AD, Kosterlitz HW. Proenkephalin- and prodynorphin-derived peptides in guinea pig heart. Neuopeptides 5:453–456;1985.
  53. Wong TM, Lee AYS. Chronic morphine treatment reduces the incidence of ventricular arrhythmias in the isolated rat heart induced by dynorphin 1–13 or myocardial ischemia and reperfusion. Neurosci Lett 77:61–65;1987.
  54. Wong TM, Lee AYS, Tai KK. Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart – an attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis. J Mol Cell Cardiol 22:1167–1175;1990.
  55. Wong-Dusting HK, Rand MJ. Effect of [D-Ala2, Met5]enkephalinamide and [D-Ala2, D-Leu5]enkephalin on cholinergic and noradrenergic neurotransmission in isolated atria. Eur J Pharmacol 111:65–72;1985.
  56. Woodcock EA, Funder JW, Johnston CI. Decreased cardiac β-adrenoceptors in hypertensive rats. Clin Exp Pharmacol Physiol 5:545–550;1978.
  57. Wu S, Li H-Y, Wong TM. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of κ-opioid receptor. Circ Res 84:1388–1395;1999.
  58. Xiao RP, Pepe S, Spurgeon HA, Capogrossi MC, Lakatta EG. Opioid peptide receptor stimulation reverses beta-adrenergic effects in rat heart cells. Am J Physiol 272:H797–H805;1997.
  59. Yu XC, Diao TM, Pei J-M, Zhang W-M, Wong TM. κ-opioid receptor agonist inhibits the cholera toxin sensitive G-protein in the heart. J Cardiovasc Pharmacol, in press.
  60. Yu XC, Li HY, Wang HX, Wong TM. U50,488H inhibits effects of norepinephrine in rat cardiomyocytes – cross-talk between κ-opioid and β-adrenergic receptors. J Mol Cell Cardiol 30:405–413;1998.
  61. Yu XC, Wang H-X, Pei J-M, Wong TM. Anti-arrhythmic effect of κ-opioid receptor stimulation in the perfused rat heart: Involvement of a cAMP-dependent pathway. J Mol Cell Cardiol 31:1809–1819;1999.
  62. Yu XC, Wang HX, Zhang WM, Wong TM. Cross-talk between cardiac κ-opioid and β-adrenergic receptors in developing hypertensive rats. J Mol Cell Cardiol 31:597–605;1999.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50